S2-scrotoncrgic receptor inhibition (ketanserin), combined with thromboxane A2/prostaglandin endoperoxide receptor blockade (BM 13.177): enhanced anti-platelet effect - Dc Clerck, F; Xhonncux, B; Van Gorp, L; Bcetcns, J; Janssen, P A J (Thromb Haemost, 1986)
(letter)